Company intelligence / Profile preview
J. Jiang Longwei
Nanjing, Jiangsu, Chinalongweipharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Jiangsu Longwei Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company specializes in a variety of therapeutic areas, including cardiovascular, anti-infective, and gastrointestinal health. With a strong emphasis on quality control and GMP-compliant manufacturing, Jiangsu Longwei serves both domestic and international markets. Their product portfolio includes a range of generic medications and specialized chemical intermediates used in drug synthesis.
- Therapeutic areas
- GastroenterologyCardiovascularInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on J. Jiang Longwei.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on J. Jiang Longwei.